(Q41143818)

27 September 2017

Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial (English)

1 reference

27 September 2017

1 reference

Liya Zhou

1

1 reference

27 September 2017

Jianzhong Zhang

2

1 reference

27 September 2017

Zhiqiang Song

3

1 reference

27 September 2017

Lihua He

4

1 reference

27 September 2017

Yanqing Li

5

1 reference

27 September 2017

Jiaming Qian

6

1 reference

27 September 2017

Peng Bai

7

1 reference

27 September 2017

Yan Xue

8

1 reference

27 September 2017

Ye Wang

9

1 reference

27 September 2017

Sanren Lin

10

1 reference

27 September 2017

23 June 2015

1 reference

27 September 2017

1 reference

27 September 2017

21

1 reference

27 September 2017

2

1 reference

27 September 2017

91-99

1 reference

Helicobacter pylori treatment in the era of increasing antibiotic resistance

27 September 2017

1 reference

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

21 January 2018

1 reference

Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection

21 January 2018

1 reference

A comparative study of sequential therapy and standard triple therapy for Helicobacter pylori infection: a randomized multicenter trial

21 January 2018

1 reference

Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection

21 January 2018

1 reference

Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori.

21 January 2018

1 reference

Pharmacologic aspects of eradication therapy for Helicobacter pylori Infection

21 January 2018

1 reference

Primary antibiotic resistance of Helicobacter pylori isolated from Beijing children

21 January 2018

1 reference

Optimal therapy for Helicobacter pylori infections

21 January 2018

1 reference

The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy

21 January 2018

1 reference

Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori

21 January 2018

1 reference

Effect of dosing schemes of amoxicillin on eradication rates of Helicobacter pylori with amoxicillin-based triple therapy

21 January 2018

1 reference

Improving compliance with helicobacter pylori eradication therapy: when and how?

21 January 2018

1 reference

Rabeprazole can overcome the impact of CYP2C19 polymorphism on quadruple therapy

21 January 2018

1 reference

Prospective multi-region study on primary antibiotic resistance of Helicobacter pylori strains isolated from Chinese patients

21 January 2018

1 reference

Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice.

21 January 2018

1 reference

Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance

21 January 2018

1 reference

New concepts of resistance in the treatment of Helicobacter pylori infections

21 January 2018

1 reference

Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of H. pylori

21 January 2018

1 reference

Rabeprazole 10 mg q.d.s. decreases 24-h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP2C19 genotype

21 January 2018

1 reference

Efficacy of tailored Helicobacter pylori eradication therapy based on antibiotic susceptibility and CYP2C19 genotype

21 January 2018

1 reference

Clarithromycin-resistant genotypes and eradication of Helicobacter pylori

21 January 2018

1 reference

Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial.

21 January 2018

1 reference

Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance

21 January 2018

1 reference

Optimizing clarithromycin-containing therapy for Helicobacter pylori in the era of antibiotic resistance

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HEL.12242

1 reference

27 September 2017

1 reference